Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
American Oriental Bioengineering, Inc.
Biotech firm's stock approved for listing on American Stock Exchange
August 10th, 2005
American Oriental Bioengineering, Inc., (AOBO), a rapidly growing Chinese company which produces and distributes a broad range of pharmaceutical and nutraceutical products, announced that its common stock has been approved for listing on the American Stock Exchange (AMEX). The company anticipates that its common stock will commence trading on AMEX on July 18, 2005, under the ticker symbol AOB. AMEX's approval for listing is contingent upon the company being in compliance with all applicable listing standards on the date it begins trading on the exchange, and may be rescinded if the company is not in compliance with such standards. ...
Source: Biotech Week (2005-08-10)
|
